TVTX
Travere Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$27.80
+0.25 ▲ +0.91%
🌙 3월 13일 7:57 PM ET (한국 3/14 08:57)
$27.80
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.6 | Insider Own | 1.89% | Shs Outstand | 0.09B | Perf Week | 2.06% |
| Market Cap | 2.56B | Forward P/E | 12.46 | EPS next Y | 491.61% | Insider Trans | -26.49% | Shs Float | 0.09B | Perf Month | -8.01% |
| Enterprise Value | 2.57B | PEG | - | EPS next Q | -0.23 | Inst Own | 113.72% | Short Float | 15.67% | Perf Quarter | -19.14% |
| Income | -0.05B | P/S | 5.23 | EPS this Y | 230.08% | Inst Trans | 1.62% | Short Ratio | 6.73 | Perf Half Y | 11.2% |
| Sales | 0.49B | P/B | 22.01 | EPS next 5Y | - | ROA | -8.38% | Short Interest | 14.18M | Perf YTD | -27.24% |
| Book/sh | 1.26 | P/C | 7.94 | EPS past 3/5Y | 49.47% 30.85% | ROE | -57.8% | 52W High | -34.01% ($42.13) | Perf Year | 45.32% |
| Cash/sh | 3.5 | P/FCF | 67.87 | Sales past 3/5Y | 64.89% 19.87% | ROIC | -11.48% | 52W Low | 115.34% ($12.91) | Perf 3Y | 27.93% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 86.22% | Gross Margin | 85.52% | Volatility(W/M) | 5.51% 5.67% | Perf 5Y | -3.27% |
| Dividend TTM | - | EV/Sales | 5.24 | Sales Y/Y TTM | 110.46% | Oper. Margin | -12.8% | ATR (14) | 1.6 | Perf 10Y | 85.21% |
| Dividend Ex-Date | - | Quick Ratio | 2.7 | EPS Q/Q | 66.42% | Profit Margin | -10.24% | RSI (14) | 42.04 | Recom | 1.27 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.74 | Sales Q/Q | 73.41% | SMA20 | -3.56% ($28.83) | Beta | 0.91 | Target Price | $42.71 |
| Payout | - | Debt/Eq | 2.86 | Earnings | 2000000 | SMA50 | -9.14% ($30.6) | Rel Volume | 0.35 | Prev Close | $27.55 |
| Employees | 497 | LT Debt/Eq | 2.81 | EPS/Sales Surpr. | 1150% -10.28% | SMA200 | 8.63% ($25.59) | Avg Volume(3M) | 2.11M | Price | $27.8 |
| IPO | 2003/10/6 | Option/Short | Yes/Yes | Trades | 9288 | Volume | 742,141 | Change | 0.91% |
뉴스 로딩 중...